首页> 外国专利> Methods and compositions for producing chondrocyte lineage cells and / or cartilage-like tissue

Methods and compositions for producing chondrocyte lineage cells and / or cartilage-like tissue

机译:产生软骨细胞谱系细胞和/或软骨样组织的方法和组合物

摘要

A method for generating chondrocytes and/or cartilage, optionally articular like non-hypertrophic chondrocyte cells and/or cartilage like tissue and/or hypertrophic chondrocyte like cells and/or cartilage like tissue, the method comprising: a. culturing a primitive streak-like mesoderm population, optionally a CD56+, PDGFRalpha+ KDR-primitive streak-like mesoderm population, with a paraxial mesoderm specifying cocktail comprising: i. a FGF agonist; ii. a BMP inhibitor; optionally Noggin, LDN-193189, Dorsomorphin; and iii. optionally one or more of a TGFbeta inhibitor, optionally SB431524; and a Wnt inhibitor, optionally DKK1, IWP2, or XAV939; to specify a paraxial mesoderm population expressing cell surface CD73, CD105 and/or PDGFR-beta; b. generating a chondrocyte precursor population comprising: i. culturing the paraxial mesoderm population expressing CD73, CD105 and/or PDGFR-beta at a high cell density optionally in serum free or serum containing media; ii. culturing the high cell density CD73+, CD105+ and/or PDGFRbeta+ paraxial mesoderm population with a TGFbeta3 agonist in serum free media to produce a high cell density Sox9+, collagen 2+ chondrocyte precursor population; and c. either i. culturing the high cell density Sox9+, collagen 2+ chondrocyte precursor population with the TGFbeta3 agonist for an extended period of time to produce an articular like non-hypertrophic chondrocyte cells and/or cartilage like tissue; or ii. culturing the high cell density Sox9+ collagen2+ chondrocyte precursor population with a BMP4 agonist for an extended period of time to produce a hypertrophic chondrocyte like cells and/or cartilage like tissue.
机译:一种产生软骨细胞和/或软骨,任选地关节样非肥大性软骨细胞和/或软骨样组织和/或肥大性软骨细胞样细胞和/或软骨样组织的方法,该方法包括:a。培养原始的条纹状中胚层群,任选地CD56 +,PDGFRalpha + KDR原始条纹状中胚层群,其中近轴中胚层指定混合物,包括:i。 FGF激动剂; ii。 BMP抑制剂;任选地Noggin,LDN-193189,Dorsomorphin; iii。任选地一种或多种TGFβ抑制剂,任选地SB431524; Wnt抑制剂,可选DKK1,IWP2或XAV939;确定表达细胞表面CD73,CD105和/或PDGFR-β的近轴中胚层种群; b。产生软骨细胞前体群体,包括:i。在无血清或含血清的培养基中以高细胞密度培养表达CD73,CD105和/或PDGFR-β的近轴中胚层种群; ii。在无血清培养基中用TGFbeta3激动剂培养高细胞密度CD73 +,CD105 +和/或PDGFRbeta +近轴中胚层群体,以产生高细胞密度Sox9 +,胶原2+软骨细胞前体群体;和c。要么我。用TGFbeta3激动剂长时间培养高细胞密度的Sox9 +,胶原蛋白2+软骨细胞前体群体,以产生关节样非肥大性软骨细胞和/或软骨样组织。或ii。用BMP4激动剂长时间培养高细胞密度的Sox9 +胶原蛋白2+软骨细胞前体群体,以产生肥大的软骨细胞样细胞和/或软骨样组织。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号